NCT03191149 2026-03-19Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangeNational Cancer Institute (NCI)Phase 2 Recruiting46 enrolled
NCT04751747 2026-01-30Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerRutgers, The State University of New JerseyPhase NA Recruiting34 enrolled